[1]王晓怀,潘文,康开彪,等.黄芪注射液治疗不稳定型心绞痛的系统评价[J].西部中医药,2013,26(10):61-64.
　WANG Xiaohuai,PAN Wen,KANG Kaibiao,et al.Systematic Review on HuangQi Injection in Treating Unstable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2013,26(10):61-64.
点击复制

黄芪注射液治疗不稳定型心绞痛的系统评价
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年10期
页码:
61-64
栏目:
出版日期:
2013-10-15

文章信息/Info

Title:
Systematic Review on HuangQi Injection in Treating Unstable Angina Pectoris
文章编号:
1004-6852(2013)10-0061-04
作者:
王晓怀1，潘文2，康开彪2，柳树英2，袁仁智1
1 甘肃省中医院，甘肃 兰州 730050； 2 甘肃省中医药研究院
Author(s):
WANG Xiaohuai1, PAN Wen2, KANG Kaibiao2, LIU Shuying2, YUAN Renzhi1
1 Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China; 2 Gansu Provincial Academy of Chinese Medicine
关键词:
黄芪注射液; 不稳定型心绞痛; 系统评价
Keywords:
HuangQi injection;  unstable angina pectoris;  systematic review
分类号:
R972+.3
文献标志码:
A
摘要:
目的：评价黄芪注射液治疗不稳定型心绞痛的疗效与安全性。方法：计算机检索MEDLINE、EMbase、Cochrane图书馆、CNKI、VIP和万方数据库，按照纳入与排除标准由两位研究者独立筛选和提取资料，采用Cochrane协作网随机对照试验的质量评价标准评价纳入文献质量，使用RevMan 5.2软件进行Meta分析。结果：共纳入6篇文献，714例患者。Meta分析结果显示：黄芪注射液组的临床疗效[RR=1.21，95%CI（1.12,1.30）]和心电图改善情况[RR=1.30，95%CI（1.15,1.46）]均优于对照组，2组相比差异有统计学意义。纳入的6篇文献中，4篇文献报道未见明显不良反应，2篇未提及安全性或不良反应。结论：黄芪注射液治疗不稳定型心绞痛，较其他常规西药和中药，可以提高其治疗效果。但由于本系统评价纳入研究质量低且样本量小，药物安全性不明确，尚需高质量随机对照试验进一步验证。
Abstract:
Objective: To evaluate therapeutic effects and the safety of HuangQi injection in treating unstable angina pectoris(UAP). Method: MEDLINE, EMbase, Cochrane library, CNKI, VIP and Wangfang database were searched; data was screened and abstracted by two investigators according to the standard of inclusion and exclusion, the quality of included literature was assessed by quality assessment of randomized controlled trial from Cochrane net and Meta analysis was performed by RevMan 5.2 software. Result: Six pieces of writing were included and 714 patients were involved. The results of Meta analysis showed: HuangQi injection group was superior to the control group in clinical effects [RR=1.21，95%CI（1.12,1.30）] and the improvements of ECG[RR=1.30，95%CI（1.15,1.46）], the difference had statistical meaning. Among six pieces of writing, there was no obvious adverse reaction in four articles, there was no safety and adverse reaction mentioned in two articles. Conclusion: HuangQi injection in treating UAP could improve therapeutic effects than other routine western medicine and herbs. Since low quality of the included research, small sample size and undefined safety of the medicine, the results need to be testified in high quality randomized controlled trials.

相似文献/References:

[1]王银娣,曹云,崔琪,等.稳心颗粒(无糖型)对不稳定型心绞痛患者冠脉介入治疗后炎性因子水平的影响[J].西部中医药,2013,26(07):23.
　WANG Yindi,CAO Yun,CUI Qi,et al.Effects of WenXin Granules (Sugar free) on the Level of Inflammatory Factors of Patients with Unstable Angina Pectoris after PCI[J].Western Journal of Traditional Chinese Medicine,2013,26(10):23.
[2]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
　REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(10):1.
[3]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
　REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(10):77.
[4]王晓怀,寇嘉宁,潘文,等.黄芪注射液治疗脑梗死的Meta分析[J].西部中医药,2014,27(10):67.
[5]杨国军.黄芪注射液对2型糖尿病患者血管功能及微循环状态的影响[J].西部中医药,2015,28(05):109.
[6]赵萍,李森.黄芪注射液联合VSD促进小腿创面肉芽组织生长的临床疗效观察[J].西部中医药,2015,28(06):108.[doi:2015/6/16 0:00:00]
[7]张征,刘长明,薛冰.丹参注射液与黄芪注射液对脑梗死大鼠急性期神经功能和梗死面积的影响[J].西部中医药,2017,30(01):17.
　ZHANG Zheng,LIU Changming,XUE Bing.The Influences of DanShen Injection and HuangQi Injection on Neurological Function and Infarct Size of Rats with Cerebral Infarction at Acute Stage[J].Western Journal of Traditional Chinese Medicine,2017,30(10):17.
[8]聂晶,郑超,李馨△.参麦注射液联合依那普利治疗老年高血压伴冠心病不稳定型心绞痛疗效观察[J].西部中医药,2017,30(11):93.
　NIE Jing,ZHENG Chao,LI Xin.Study on Clinical Effects of ShenMai Injection Combined with Enalapril in the Treatment of Senile Hypertension Complicated with CHD Unstable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2017,30(10):93.
[9]吴正国,邹琴△.黄芪注射液治疗慢性心力衰竭的Meta分析[J].西部中医药,2018,31(02):54.
　WU Zhengguo,ZOU Qin.Meta Analysis of HuangQi Injection in Treating Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2018,31(10):54.
[10]郝珊瑚,纪立秋,王治国,等.黄芪注射液联合131I核素治疗分化型甲状腺癌临床研究[J].西部中医药,2020,33(03):97.[doi:10.12174/j.issn.1004-6852.2020.03.27]
　HAO Shanhu,JI Liqiu,WANG Zhiguo,et al.Clinical Study on Huangqi Injection Combined with 131I Nuclide in the Treatment of Differentiated Thyroid Cancer[J].Western Journal of Traditional Chinese Medicine,2020,33(10):97.[doi:10.12174/j.issn.1004-6852.2020.03.27]

备注/Memo

备注/Memo:
收稿日期：2013-04-10 作者简介：王晓怀(1981—)，男，硕士学位，医师。研究方向：医学信息、循证医学的研究。
更新日期/Last Update: 2013-10-15